What’s the latest in prebiotic research? April Edition
What’s the latest in prebiotic research? April Edition This monthly feature provides an overview of some of the latest studies on prebiotics. We’ll share key findings and insights from the…
What’s the latest in prebiotic research? April Edition This monthly feature provides an overview of some of the latest studies on prebiotics. We’ll share key findings and insights from the…
Mushrooms blend dose-dependently increases butyrate production by the gut microbiota Researchers at the Netherland’s Maastricht University examined the effect of a predigested blend of 3 mushrooms at three doses (0.5,…
Prebiotics and impact on resilience to circadian rhythms disruptions Research on rats, funded by the US Navy, conducted at the University of Colorado-Boulder and published in the journal Brain, Behavior…
Flavonoid-rich Foods, Microbial Diversity and Abundance of Parabacteroides and Impact on Blood Pressure According to a study published in the journal Hypertension, researchers examined over 900 German subjects determining that…
Parkinson’s disease limits short chain fatty acids production In a study published in the journal Nature, researchers investigated different fiber supplements’ effects on short-chain fatty acid production, along with potential…
NHSc’s HMO blend deemed effective for babies allergic to cow’s milk protein According to research presented at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid 2021 Congress, AAF, Alfamino…
ILSI, the EU-based International Life Sciences Institute, published a document describing ‘Dietary Fibre in Europe – Current State of Knowledge on Definitions, Sources, Recommendations, Intakes and Relationships to Health’.
New research (nt. J. Mol. Sci. 2017) examined the impact of a prebiotic, based on Galacto-oligosaccharides (GalOS) with β-1,6 and β-1,3 linkages, on markers of colorectal cancer in Wister rats.
A prebiotic nanofibre matrix that protects beneficial bacteria in the low pH environment of fruit juices could prove an effective encapsulation agent for the probiotic delivery in functional beverages.
Caret Pharma, subsidiary of a company that focuses on medical foods for intestinal conditions, announced that it will acquire Fiber Choice, a line of fiber supplements.